Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
In today’s health headlines, could skin conditions like eczema and psoriasis put other aspects of your health in jeopardy? Plus, expert tips for dry, wintery skin.